| scholarly article | Q13442814 |
| P2093 | author name string | Wei Shi | |
| Marinos C Dalakas | |||
| Cristina Semino-Mora | |||
| Goran Rakocevic | |||
| Raghavan Raju | |||
| Ziwei Chen | |||
| Gerard Hoehn | |||
| Richard Olsen | |||
| P433 | issue | Pt 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stiff-person syndrome | Q1235785 |
| P304 | page(s) | 3270-3276 | |
| P577 | publication date | 2006-09-19 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome | |
| P478 | volume | 129 |
| Q46522686 | 11C-flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with Stiff Person Syndrome |
| Q48021708 | A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome |
| Q34589713 | Advances in the pathogenesis and treatment of patients with stiff person syndrome |
| Q35182392 | Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. |
| Q37691267 | Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders |
| Q28264405 | Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes |
| Q37278022 | B cells as therapeutic targets in autoimmune neurological disorders |
| Q34639863 | C-terminal modification is required for GABARAP-mediated GABA(A) receptor trafficking. |
| Q27006941 | Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms |
| Q48122020 | Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases |
| Q46730187 | GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies |
| Q85723256 | GABAergic changes in (11)C-flumazenil PET in the drug-naïve Stiff-Person syndrome |
| Q95840283 | GAD antibodies in neurological disorders - insights and challenges |
| Q51210635 | GAD65 neurological autoimmunity. |
| Q27437613 | Human stiff-person syndrome IgG induces anxious behavior in rats |
| Q37774097 | Immune dysfunction in autism: a pathway to treatment |
| Q37094697 | Immunobiology of stiff-person syndrome |
| Q38156224 | Immunology of stiff person syndrome and other GAD-associated neurological disorders |
| Q42530496 | Interactions of Human Autoantibodies with Hippocampal GABAergic Synaptic Transmission - Analyzing Antibody-Induced Effects ex vivo |
| Q45302692 | Levetiracetam in stiff-person syndrome |
| Q36993609 | Movement disorders in paraneoplastic and autoimmune disease. |
| Q34359264 | Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome. |
| Q36812520 | Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system |
| Q44922918 | Paraneoplastic neurological syndromes: general treatment overview |
| Q38020957 | Pathogenic and physiological autoantibodies in the central nervous system |
| Q34468359 | Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells |
| Q60921333 | Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder |
| Q26768678 | Recent Advances and Review on Treatment of Stiff Person Syndrome in Adults and Pediatric Patients |
| Q34162658 | Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia |
| Q26770774 | Spinal-generated movement disorders: a clinical review |
| Q58774499 | Stiff person syndrome with elevated titers of antibodies against cardiolipin and β2 glycoprotein 1: a case report and literature review |
| Q42477784 | Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition |
| Q48751128 | Stiff person syndrome: advances in pathogenesis and therapeutic interventions |
| Q48681089 | Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms |
| Q56883348 | Stiff-person syndrome |
| Q37834590 | Stiff-person syndrome: a case report and review of the literature |
| Q38289691 | Stiff-person syndrome: insights into a complex autoimmune disorder |
| Q35858036 | The adaptive immune system in diseases of the central nervous system |
| Q28295552 | The immunological basis for treatment of stiff person syndrome |
Search more.